Molecular Templates Inc Stock News

If you're interested in Molecular Templates, Inc. (NASDAQ:MTEM), then you might want to consider its beta (a measure...

As of late, it has definitely been a great time to be an investor Molecular Templates

Menlo Therapeutics (NASDAQ:MNLO) initiated with Overweight rating and $8 (161% upside) price target at Barclays.Molecular Templates (NASDAQ:MTEM) initiated with Buy rating and $19 (43% upside) price t

Catalyst's (CPRX) earnings lag estimates in the fourth quarter. Revenues match the same.

Catalyst's (CPRX) earnings lag estimates in the fourth quarter. Revenues match the same.

Take advantage of panic selling with these 7 cheap stocks.

Take advantage of panic selling with these 7 cheap stocks.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Templates (MTEM) and Synlogic (SYBX). Molecular

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Templates (MTEM

AUSTIN, Texas, March 12, 2020 -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu

AUSTIN, Texas, Feb. 28, 2020 -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Molecular Templates (MTEM), Atricure (ATRC) and Fate

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Molecular Templates

Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary en